TABLE 2.
Baseline characteristics of the subjects at entry1
| CLA |
Placebo |
|||
| Males | Females | Males | Females | |
| Race-ethnicity (n) | ||||
| White | 12 | 11 | 13 | 8 |
| Black | 2 | — | — | 2 |
| Asian | 1 | 1 | 2 | — |
| Hispanic | 1 | — | — | — |
| No. of subjects | 16 | 12 | 15 | 10 |
| Age (y) | 8.8 ± 1.32 | 8.6 ± 0.8 | 9.3 ± 0.8 | 8.1 ± 0.6 |
| Weight (kg) | 45.6 ± 16.5 | 43.8 ± 8.7 | 42.9 ± 6.8 | 38.1 ± 7.1 |
| Height (cm) | 139 ± 8 | 136 ± 73 | 140 ± 8 | 130 ± 3 |
| BMI (kg/m2) | 23.0 ± 5.7 | 23.3 ± 2.8 | 21.8 ± 1.9 | 22.5 ± 3.4 |
| BMI (%)4 | 95.1 ± 3.4 | 96.1 ± 2.8 | 94.6 ± 3.2 | 94.6 ± 5.2 |
| BMI z score | 1.7 ± 0.5 | 2.0 ± 0.4 | 1.5 ± 0.4 | 1.9 ± 0.5 |
1
CLA, conjugated linoleic acid.
2
Mean ± SD (all such values).
3
Significantly different from placebo within the same sex, P ≤ 0.05.
4
BMI percentile based on Centers for Disease Control and Prevention growth charts (19).